Rosuvastatin & Fenofibrate Tablets IP – Noruva F Tablets

NORUVA F Tablets – Dual Action Therapy for Cholesterol & Triglyceride Control.

NORUVA F Tablets – The dual combination of Rosuvastatin & Fenofibrate Tablets IP provides comprehensive lipid management in patients with dyslipidemia:
Rosuvastatin – A potent statin used to lower cholesterol levels. It reduces LDL cholesterol (the “bad” cholesterol), increases HDL cholesterol (the “good” cholesterol), and slows the progression of atherosclerosis.
Fenofibrate – A fibrate that primarily targets high triglyceride levels, lowers triglycerides, and modestly increases HDL cholesterol.

Key Benefits of Rosuvastatin & Fenofibrate Tablets – NORUVA F Tablets
✅ Dual Lipid Control – Effectively targets both high LDL and triglycerides, ideal for mixed dyslipidemia.
✅ Enhanced Heart Protection – Provides comprehensive cardiovascular risk reduction, especially for high-risk patients.
✅ Synergistic Action – Rosuvastatin lowers LDL, while Fenofibrate reduces triglycerides for optimal lipid management.
✅ Faster Results – Achieves significant lipid reduction quicker than single-drug therapies.
✅ Prevents Lipid-related Complications – Reduces the risk of atherosclerosis and other lipid-related cardiovascular issues.

Recommended By Specialists:
👨‍⚕️ Cardiologists: Commonly recommend to high-risk cardiac patients to minimize complications like atherosclerosis associated with high cholesterol or lipid levels.
👨‍⚕️ General Physicians: Often prescribe to control high LDL cholesterol levels and manage associated conditions such as hypercholesterolemia, mixed dyslipidemia, and hypertriglyceridemia.

INDICATIONS:
✅ Mixed dyslipidemia
✅ Primary hypercholesterolemia with elevated triglycerides
✅ Hypertriglyceridemia
✅ Atherosclerosis